Prof. John McCarron likes mountains, and lies about mountains (it'll be fun he said), and likes going up mountains. He loves hills that much he's almost over one...Prof. John McCarron likes mountains, and lies about mountains (it'll be fun he said), and likes going up mountains. Prof. John McCarron likes mountains, and lies about mountains (it'll be fun he said), and likes going up mountains. Prof. John McCarron likes mountains, and lies about mountains (it'll be fun he said), and likes going up mountains. Prof. John McCarron likes mountains, and lies about mountains (it'll be fun he said), and likes going up mountains. Prof. John McCarron likes mountains, and lies about mountains (it'll be fun he said), and likes going up mountains. Prof. John McCarron likes mountains, and lies about mountains (it'll be fun he said), and likes going up mountains.
In his spare time, John likes going up mountains.
Dr Helen Heathcote BSc, MRes, PhD
Post Doctoral Research Associate
Helen's previous research has focused mainly on cellular signalling mechanisms in the vasculature, in particular how these are altered in disease states such as cardiovascular disease and diabetes.
Helen was awarded her PhD in Vascular Pathophysiology and Therapeutics in 2016 by the University of Glasgow and shortly afterwards took up her current position as a Post Doctorate Research Associate at the University of Strathclyde.
Typically using cell culture models and biochemical analysis methods during her PhD, Helen is now imaging cell signalling events in intact arteries using the technology developed within the McCarron group.
Contact Helen via:
email: helen.heathcote@strath.ac.uk
researchgate: https://www.researchgate.net/profile/Helen_Heathcote
Publications
2020
Wilson, C, Zhang, X, Lee, MD, MacDonald, M, Heathcote, HR, Alorfi, NMN, Buckley, C, Dolan, S, McCarron, JG 2019, 'Disrupted endothelial cell heterogeneity and network organization impair vascular function in prediabetic obesity'. Metabolism. DOI: 10.1016/j.metabol.2020.154340
2019
Wilson, C, Zhang, X, Buckley, C, Heathcote, H, Lee, MD, McCarron, JG 2019, 'Increased Vascular Contractility in Hypertension Results From Impaired Endothelial Calcium Signaling' Hypertension. DOI: 10.1161/HYPERTENSIONAHA.119.13791
Heathcote, H, Lee, MD, Zhang, X, Wilson, C, McCarron, JG,(2019). Endothelial TRPV4 channels modulate vascular tone by Ca2+-induced Ca2+ release at IP3 receptors. British Journal of Pharmacology DOI: 10.1111/bph.14762
McCarron, JG, Wilson, C, Heathcote, H, Zhang, X, Buckley, C, and Lee, MD (2019). Heterogeneity and emergent behaviour in the vascular endothelium. Current Opinions in Pharmacology DOI: 10.1016/j.coph.2019.03.008
Wilson, C, Lee, MD, Heathcote, H, Zhang, X, Buckley, C, Girkin, JM, Saunter, CD, McCarron, JG 2019, 'Mitochondrial ATP production provides long-range control of endothelial inositol trisphosphate–evoked calcium signaling' Journal of Biological Chemistry. DOI: 10.1074/jbc.RA118.005913
2016
Heathcote H.R., Mancini S.J., Strembitska, A., Jamal, K., Reihill, J.A., Palmer, T.M., Gould, G.W., Salt, I.P. 2016.
Protein kinase C phosphorylates AMP-activated protein kinase α1 Ser487. Biochemical Journal.15;473(24):4681-4697. PMID: 27784766 DOI: 10.1042/BCJ20160211
2013
Hudson, B.D., Shimpukade, B., Mackenzie, A.E., Butcher, A.J., Pediani, J.D., Christiansen, E., Heathcote, H., Tobin, A.B., Ulven, T. and Milligan, G., 2013. The pharmacology of a potent and selective agonist, TUG-891, demonstrates both potential opportunity and possible challenges to therapeutic agonism of FFA4 (GPR120). Molecular pharmacology, pp.mol-113. DOI: 10.1124/mol.113.087783